Repligen RGEN
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–
RGEN Stock News
Headlines matching Repligen or the RGEN ticker, most recent first.
- UBS Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225
- Stifel Maintains Repligen(RGEN.US) With Buy Rating
- Wells Fargo Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $185
- Benchmark Co. Upgrades Repligen(RGEN.US) to Buy Rating, Announces Target Price $185 Positive
- Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160 Positive
- Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
- Wells Fargo Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $185 Positive
- J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175 Positive
- A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $175 to $200
- CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $145
- RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
- Barclays Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
- William Blair Maintains Repligen(RGEN.US) With Buy Rating
- Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating
- Wolfe Research Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $145
No comments yet — be the first to weigh in on RGEN.
Sign in to join the discussion.